At a Glance
  • Status: Active Consortium
  • Year Launched: 2006
  • Initiating Organization: The University of Southampton (UK)
  • Initiator Type: Academia
  • Disease focus:
    Obesity, Type 2 Diabetes
  • Location: International


EPIGEN is an international, collaborative group of leading epilepsy research, formed with the goal of applying genomics to epilepsy therapeutics and predisposition. The consortium stands at the forefront of this next phase of epilepsy genetics research. EPIGEN is delivering a highly interactive and translational genetics research program incorporating patients actively seen in clinics, their clinicians, and scientists to improve knowledge of epilepsy and better the lives of those living with this condition.

Consortium History

EPIGEN was formed in 2005.


Sponsors & Partners

Beaumont Hospital and the Royal College of Surgeons in Ireland

Duke University

Universite Libre de Bruxelles

University College London

Last Updated: 04/14/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.